Medicare Advantage Insurers Overcharged Taxpayers by $18 Billion in 2024, Watchdog Finds

A comprehensive review of Medicare Advantage payments has uncovered that for-profit insurers overcharged federal taxpayers and beneficiaries by $18 billion in 2024. The findings, based on federal data and audit methodologies, highlight that payments to insurers exceeded actual care delivery costs, particularly in regions with high enrollment and concentrated market share. UnitedHealth Group (UNH), the largest player in the Medicare Advantage market with over 26 million members, was identified as the top recipient of excess funds, accounting for more than $6.3 billion of the total overpayments. Johnson & Johnson (JNJ), through its subsidiary UnitedHealthcare, also contributed to the surplus through its managed care contracts, with internal cost allocation data indicating inflated administrative and network payments. The audit analyzed claims data from over 50 million Medicare Advantage enrollees across 16 states, revealing a pattern of overbilling tied to inflated risk adjustment scores and inaccurate beneficiary health assessments. These scores, used to determine federal payments, were found to be disproportionately high in markets dominated by a single insurer. In some ZIP codes, insurers received 30% more in federal payments per beneficiary than the actual cost of care. The U.S. Department of Health and Human Services (HHS) has since launched an internal review and signaled potential adjustments to payment formulas. The implications extend beyond fiscal waste. The overpayments distort market competition, enabling dominant insurers to reinvest surplus funds into marketing and lobbying rather than patient care. This dynamic threatens long-term sustainability of the Medicare Advantage program and raises concerns about equity in access. As a result, investor sentiment toward health insurers has cooled, with XLV, the Health Care Select Sector SPDR Fund, declining 4.2% in early trading following the release of the report. Analysts now project a 6–10% downward revision in earnings forecasts for major health insurers in 2025. Regulatory action is expected to follow, with lawmakers proposing legislation to cap risk adjustment payments and increase transparency in insurer cost reporting. The findings could lead to a federal clawback of overpaid funds and stricter compliance requirements. Insurers are preparing for potential audits, while consumer advocacy groups are demanding reforms to ensure taxpayer dollars are used efficiently.